Enhancing Palliative Care in ICU

NCT06605079 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2040

Last updated 2025-09-30

No results posted yet for this study

Summary

The aim of this study is to reduce the suffering in intensive care through palliative care consultations.

Conditions

  • Palliative Care

Interventions

BEHAVIORAL

Complex intervention

A complex intervention is carried out in the intensive care unit. This includes: * telemedical consultations by specialized palliative care experts from external institutions for the respective hospital staff * the training of hospital staff in the intensive care unit in basic palliative care and * the use of checklists for the early identification of eligible patients and the structured recording of palliative care needs. The efficacy and cost-effectiveness of the complex intervention will be investigated using a controlled clinical trial in a cluster-randomized controlled design. In addition, as part of the multicenter clinical study in WP 2 staff, patients and relatives will also be surveyed.

OTHER

Routine treatment

No complex intervention is established, just routine procedures.

Sponsors & Collaborators

Principal Investigators

  • Claudia Spies, MD, Prof. · Charité-University Medicine (Berlin, Germany)

  • Martin Neukirchen, MD · Heinrich-Heine-University Düsseldorf, Germany

  • Jochen Dutzmann, MD · University Medicine Halle, Germany

  • Spyros Mentzelopoulos, MD, Prof. · National and Kapodistrian University of Athens, Greece

  • Katerina Rusinova, MD · Charles University in Prague, Italy

  • Akiva Nachshon, MD · Hebrew University of Jerusalem, Israel

  • Edoardo de Robertis, MD, Prof. · University Of Perugia

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-10-10
Primary Completion
2027-05-31
Completion
2027-08-31

Countries

  • Czechia
  • Germany
  • Greece
  • Israel
  • Italy

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06605079 on ClinicalTrials.gov